BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15693851)

  • 1. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of claudin expression in pancreatic cystic tumors.
    Lee JH; Kim KS; Kim TJ; Hong SP; Song SY; Chung JB; Park SW
    Oncol Rep; 2011 Apr; 25(4):971-8. PubMed ID: 21206985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
    Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
    Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
    Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
    Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
    Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
    J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and morphological characteristics of intraductal papillary mucinous tumors of the pancreas].
    Dubova EA; Shchegolev AI
    Arkh Patol; 2009; 71(2):9-12. PubMed ID: 19507570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.